Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RI
Good perspective. But: It is important to be certain the screening is actually getting done, not just that patients enroll on a trial. For example you can’t benefit if the colonoscopy isn’t done in an intent-to-screen analysis that includes patients who never get the screening. https://lnkd.in/e-6URp57 Doing more cancer screening won't reduce Black-white health disparities https://lnkd.in/ewBDji-5
